☆ 4.6 Article

Interactive process mining of cancer treatment sequences with melanoma real-world data

FRONTIERS IN ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Michael B. Atkins et al.

Summary: Combination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4-blockade and dual BRAF/MEK inhibition have shown significant clinical benefit in patients with BRAFV600-mutant metastatic melanoma. This study aimed to determine the best initial treatment or treatment sequence in this population.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

Jedd D. Wolchok et al.

Summary: The 6.5-year results of the CheckMate 067 trial demonstrate durable clinical benefits with nivolumab plus ipilimumab or nivolumab monotherapy compared to ipilimumab alone in patients with advanced melanoma.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Computer Science, Software Engineering

A Framework for Evaluating Dashboards in Healthcare

Mengdie Zhuang et al.

Summary: In this article, the authors systematically review the implementation of dashboards in healthcare and analyze evaluation methods. They propose a general definition of dashboards and introduce seven evaluation scenarios. The paper provides detailed explanations of each scenario and showcases the use of the proposed framework through a design study.

IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS (2022)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Process mining for healthcare: Characteristics and challenges

Jorge Munoz-Gama et al.

Summary: Process mining techniques are not widely used in healthcare beyond targeted case studies, and there is a need for further research and improvement to consider the characteristics of healthcare processes.

JOURNAL OF BIOMEDICAL INFORMATICS (2022)

Add to Collection

Review Medical Informatics

Requirements and challenges of hospital dashboards: a systematic literature review

Reza Rabiei et al.

Summary: This systematic review aimed to identify functional and non-functional requirements, as well as challenges of using dashboards in hospitals. The results showed that the functional requirements for dashboards included reporting, reminders, customization, etc., while non-functional requirements included speed, security, ease of use, etc. The identified challenges mainly involved data sources, dashboard content, design, and implementation.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2022)

Add to Collection

Article Oncology

First-line immunotherapy versus targeted therapy in patients withBRAF-mutant advanced melanoma: a real-world analysis

Anna C. Pavlick et al.

Summary: In a study comparing nivolumab + ipilimumab (NIVO + IPI) with BRAF + MEK inhibitors (BRAFi + MEKi) in patients with BRAF-mutant advanced melanoma, NIVO + IPI was associated with a 32% lower risk of death and higher survival rates at a mean follow-up of 15-16 months. Patients receiving first-line NIVO + IPI also had a lower mortality rate before subsequent therapy compared to those receiving first-line BRAFi + MEKi.

FUTURE ONCOLOGY (2021)

Add to Collection

Review Health Care Sciences & Services

An Architectural Framework for Healthcare Dashboards Design

Saeed Rouhani et al.

Summary: In the competitive environment of today, the use of business or organizational dashboards as a tool in the field of information technology has become increasingly important. This research provides a framework for designing healthcare dashboards by extracting and analyzing articles using methods like metasynthesis to identify key principles for guiding the design of enterprise dashboards.

JOURNAL OF HEALTHCARE ENGINEERING (2021)

Add to Collection

Review Oncology

Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis

Alessandro Inno et al.

Summary: The role of immune checkpoint inhibitor (ICI) rechallenge in cancer patients is not well-defined, but current data suggest it may be an active and feasible strategy. Further prospective studies are needed to clarify the role of ICI rechallenge after disease progression or adverse events.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Add to Collection

Article Oncology

The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients

Anne Zaremba et al.

Summary: The review evaluated the latest long-term data from clinical trials for melanoma patients, showing that retreatment, rechallenge, and escalation are viable options for patients who relapse in the adjuvant or advanced setting.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Meeting Abstract Oncology

CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma.

Jedd D. Wolchok et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medical Informatics

A National, Semantic-Driven, Three-Pillar Strategy to Enable Health Data Secondary Usage Interoperability for Research Within the Swiss Personalized Health Network: Methodological Study

Christophe Gaudet-Blavignac et al.

Summary: The interoperability challenge in medical informatics remains crucial despite initiatives and investments. The Swiss Personalized Health Network (SPHN) initiative aims to build a national infrastructure for reusing consented data acquired in the health care and research system to enable research in the field of personalized medicine in Switzerland. This strategy successfully implemented existing standards in a pragmatic and applicable way, bringing the Swiss landscape into a new dimension to support research in the field of personalized medicine and large interoperable clinical data.

JMIR MEDICAL INFORMATICS (2021)

Add to Collection

Review Dermatology

Rechallenge with checkpoint inhibitors in metastatic melanoma

Robin Reschke et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2020)

Add to Collection

Article Oncology

Long-term survival from pembrolizumab (pembro) completion and pembro retreatment: Phase III KEYNOTE-006 in advanced melanoma.

Georgina V. Long et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Health Care Sciences & Services

Improving Health Care Management in Hospitals Through a Productivity Dashboard

Miguel Pestana et al.

JOURNAL OF MEDICAL SYSTEMS (2020)

Add to Collection

Article Environmental Sciences

What Role Can Process Mining Play in Recurrent Clinical Guidelines Issues? A Position Paper

Roberto Gatta et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Add to Collection

Article Oncology

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

O. Hamid et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Review Oncology

Real-world data: towards achieving the achievable in cancer care

Christopher M. Booth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Add to Collection

Article Environmental Sciences

Toward Value-Based Healthcare through Interactive Process Mining in Emergency Rooms: The Stroke Case

Gema Ibanez-Sanchez et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Add to Collection

Article Medicine, General & Internal

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Environmental Sciences

Process Mining Dashboard in Operating Rooms: Analysis of Staff Expectations with Analytic Hierarchy Process

Antonio Martinez-Millana et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Add to Collection

Proceedings Paper Computer Science, Theory & Methods

Process mining in oncology using the MIMIC-III dataset

Angelina Prima Kurniati et al.

INTERNATIONAL CONFERENCE ON DATA AND INFORMATION SCIENCE (ICODIS) (2018)

Add to Collection

Article Business

Assessing the conformity to clinical guidelines in oncology: An example for the multidisciplinary management of locally advanced colorectal cancer treatment

Jacopo Lenkowicz et al.

MANAGEMENT DECISION (2018)

Add to Collection

Review Computer Science, Interdisciplinary Applications

Process mining in healthcare: A literature review

Eric Rojas et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2016)

Add to Collection

Editorial Material Medicine, General & Internal

Real-World Evidence - What Is It and What Can It Tell Us?

Rachel E. Sherman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Oncology

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Add to Collection

Article Medicine, General & Internal

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Oncology

BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma

Maria Colombino et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Add to Collection

Article Medicine, General & Internal

Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib

Jeffrey A. Sosman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Oncology

Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

Evan J. Lipson et al.

CLINICAL CANCER RESEARCH (2011)

Add to Collection

Article Oncology

Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma

Georgina V. Long et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Review Oncology

BRAF targeted therapy changes the treatment paradigm in melanoma

Antoni Ribas et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Add to Collection

Article Medicine, General & Internal

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Add to Collection

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.